Back to search
FDAFDA · Food and drugs·Recall number D-1201-2016

LIPO W/LIDOCAINE #3 W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;D3-30MG; B5-5MG;B6-5MG;CYANO B12-1MG; METHIONINE 12.5MG; INOSITOL-25MG; CHOLINE CL-25 MG; LIDOCAINE 10MG/ML, In a) 5 ML Vials and b) 10ML Vials, MEDAUS PHARMACY

Published July 20, 2016 · Recall initiated: May 13, 2016

Summary

FDA records drug Class II recall D-1201-2016, published July 20, 2016 and initiated May 13, 2016. Recalling firm: Medaus, Inc.; Status: Terminated; Reported quantity: 7000 mL in Vials; Lot: a) Lot #: 160107-37, BUD: 07/5/16; Lot #: 160303-67, BUD: 07/31/16. b) Lot #: 160107-37, BUD: 07/5/16; Lot #: 160303-67, BUD: 07/31/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medaus, Inc.
Distributor
U.S. Nationwide, Japan, and New Zealand.
Lot
a) Lot #: 160107-37, BUD: 07/5/16; Lot #: 160303-67, BUD: 07/31/16. b) Lot #: 160107-37, BUD: 07/5/16; Lot #: 160303-67, BUD: 07/31/16.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was LIPO W/LIDOCAINE #3 W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;D3-30MG; B5-5MG;B6-5MG;CYANO B12-1MG; METHIONINE 12.5MG; INOSITOL-25MG; CHOLINE CL-25 MG; LIDOCAINE 10MG/ML, In a) 5 ML Vials and b) 10ML Vials, MEDAUS PHARMACY recalled?

Yes. FDA published recall D-1201-2016 on July 20, 2016. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail